Aspira women's health announces publication of real-world data validating use of ovawatch for the management of adnexal masses

Provides clinical validation for the use of ovawatch sm in the assessment of ovarian cancer risk for suspected benign or indeterminate adnexal masses

AWH Ratings Summary

AWH Quant Ranking